ATRA also can inhibit RKO colorectal cancer cell migration by downregulating myosin light-chain kinase expression via the extracellular signal-regulated kinase-1/Mitogen-activated protein kinase signalling pathway34. This evidence concerns the gene WNK2 and colorectal cancer.